Press "Enter" to skip to content

U.S. FDA panel recommends approval of Johnson & Johnson’s depression drug

An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended Johnson & Johnson’s experimental nasal spray, which has a compound similar to often-abused ketamine, for patients suffering from depression.

Original source: https://health.economictimes.indiatimes.com/news/pharma/u-s-fda-panel-recommends-approval-of-johnson-johnsons-depression-drug/67972425?utm_source=RSS&utm_medium=ETRSS

Also Read:   3% drugs in Tamil Nadu 'not of standard quality'